Approved Formulary
Add Formweb to your mobile device
Approved Formulary
Black Box Warning: Increased CV and Endometrial Cancer Risk
Search results for:
ESTRADIOL TOPICAL
ESTRADIOL TOPICAL
| Drug Name | Form | Strength | Non-Formulary | Notes |
|---|---|---|---|---|
| ESTRACE VAGINAL CREAM | CREAM | 0.1 mg/gm | ||
| EVAMIST | SPRAY | 1.53 mg estradiol/spray | ||
| ALORA | TRANSDERMAL PATCH | 0.025 MG/24 HOURS (TWICE WEEKLY) | ||
| CLIMARA | TRANSDERMAL PATCH | 0.025 MG/24 HOURS (WEEKLY) | ||
| CLIMARA | TRANSDERMAL PATCH | 0.0375 MG/24 HOURS (WEEKLY) | ||
| ALORA | TRANSDERMAL PATCH | 0.05 MG/24 HOURS (TWICE WEEKLY) | ||
| CLIMARA | TRANSDERMAL PATCH | 0.05 MG/24 HOURS (WEEKLY) | ||
| ESCLIM | TRANSDERMAL PATCH | 0.05 MG/24 HOURS (TWICE WEEKLY) | ||
| CLIMARA | TRANSDERMAL PATCH | 0.06 MG/24 HOURS (WEEKLY) | ||
| ALORA | TRANSDERMAL PATCH | 0.075 MG/24 HOURS (TWICE WEEKLY) | ||
| CLIMARA | TRANSDERMAL PATCH | 0.075 MG/24 HOURS (WEEKLY) | ||
| ESCLIM | TRANSDERMAL PATCH | 0.075 MG/24 HOURS (TWICE WEEKLY) | ||
| VIVELLE | TRANSDERMAL PATCH | 0.075 MG/DAY (TWICE WEEKLY) | ||
| ALORA | TRANSDERMAL PATCH | 0.1 MG/24 HOURS (TWICE WEEKLY) | ||
| ESCLIM | TRANSDERMAL PATCH | 0.1 MG/24 HOURS (TWICE WEEKLY) | ||
| ESCLIM | TRANSDERMAL PATCH | 0.25 MG/24 HOURS (TWICE WEEKLY) |
Last updated: Sep. 25, 2014
- Black Box Warning: Increased CV and Endometrial Cancer Risk